Update shared on07 Aug 2025
Fair value Increased 30%The consensus price target for Yatharth Hospital & Trauma Care Services has been raised to ₹633.33, reflecting increased valuation expectations despite a lower net profit margin and a higher future P/E multiple.
What's in the News
- Inaugurated a new 300-bed super speciality hospital in Model Town, New Delhi, expanding group capacity to over 2,300 beds across 7 hospitals.
- Shifted corporate office to Second Floor, Sovereign Capital Gate, FC-12 Sector 16A, Noida, Gautam Buddha Nagar, Uttar Pradesh - 201301.
- Board Meeting scheduled to consider and approve Un-Audited Financial Results for Q1 ended June 30, 2025.
- Board Meeting held to consider and approve Audited Financial Results for the year ended March 31, 2025.
- Expected to report Q1 2026 results on August 6, 2025.
Valuation Changes
Summary of Valuation Changes for Yatharth Hospital & Trauma Care Services
- The Consensus Analyst Price Target has risen from ₹598.00 to ₹633.33.
- The Future P/E for Yatharth Hospital & Trauma Care Services has significantly risen from 29.41x to 35.86x.
- The Net Profit Margin for Yatharth Hospital & Trauma Care Services has fallen from 15.43% to 14.29%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.